BTAI Stock Ownership Activity

BIOXCEL THERAPEUTICS INC 13F holders

1 value investing guru has made changes to the BIOXCEL THERAPEUTICS INC (BTAI) position according to the gurus' latest SEC quarterly report(s). BTAI has been bought (as a new position) by 1 guru(s)

Which gurus or hedge funds are buying BTAI now?

According to the latest SEC filing(s) BIOXCEL THERAPEUTICS INC (BTAI) has been bought by Howard Marks - Oaktree Capital Management (new buy).

To see more about who is investing in BIOXCEL THERAPEUTICS INC (BTAI), please go to the BTAI ownership page.

2025 Q2 (1 result)
Howard Marks
buy
+241,188
+0.01%
0.01%
Current price: $4.75 162.43% Reported price*: $1.81
1 of 1

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.